Premium
P1‐188: PREVALENCE AND RISK FACTORS OF COGNITIVE IMPAIRMENT IN PATIENTS WITH DIABETES
Author(s) -
Alaama Tareef,
Basheikh Mohammed,
Mitwalli Madhawi,
Khiyami Anamil
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.426
Subject(s) - montreal cognitive assessment , medicine , dementia , diabetes mellitus , cognition , cognitive impairment , population , body mass index , correlation , physical therapy , psychiatry , disease , endocrinology , geometry , environmental health , mathematics
Mean Age (SD) 60.4 (8.76) years 56.3 (8.2) years Females (%) 84 (49%) 33 (49%) Mean years of education (SD) 6.346 5.9 years 7.57 6 6 years Presence of depression (%) 37 (21.6%) 13 (19.1%) Mean Arterial Pressure (SD) 101.99617.6, 100.84615.75 Cerebrovascular disease. (%) 18 (10.5) 4 (5.9) Neuroactive Medications (%) 4 (2.3) 5(7.4) Body Mass Index (SD) 31.866.6 32.166.9 Constantine Lyketsos, Steven D. Targum, Kristin Drake, J. Cara Pendergrass, Cynthia Munro, Gwenn Smith, Andres M. Lozano, Johns Hopkins University, Baltimore, Maryland, United States; Clintara LLC, Boston, Massachusetts, United States; Functional Neuromodulation Ltd., Toronto, Ontario, Canada; Johns Hopkins University, Baltimore, Maryland, United States; Toronto General Hospital, Toronto, Ontario, Canada. Contact e-mail: sdtargum@yahoo.com